Veterinary Medicine Information website

Zerofen 25 mg/ml Oral Suspension

Authorised
  • Fenbendazole
Download as PDF

Product identification

Medicine name:
Zerofen 25 mg/ml Oral Suspension
Active substance:
  • Fenbendazole
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Fenbendazole
    2.50
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        14
        day
      • Milk
        96
        hour
    • Sheep
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • A suspension contained in 10 L high density polythene containers with polypropylene closures.
  • A suspension contained in 5 L high density polythene containers with polypropylene closures.
  • A suspension contained in 2.5 high density polythene containers with polypropylene closures.
  • A suspension contained in 1 L high density polythene containers with polypropylene closures.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10987/017/002
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 25/09/2024
Download